A detailed history of Stewart & Patten CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Stewart & Patten CO LLC holds 6,460 shares of AMGN stock, worth $2.04 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
6,460
Previous 6,460 -0.0%
Holding current value
$2.04 Million
Previous $1.86 Million 1.29%
% of portfolio
0.28%
Previous 0.29%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $102,280 - $115,383
-400 Reduced 5.83%
6,460 $1.86 Million
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $407,113 - $481,403
1,900 Added 38.31%
6,860 $1.52 Million
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $45,806 - $58,202
-200 Reduced 3.88%
4,960 $1.3 Million
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $44,892 - $50,630
-200 Reduced 3.73%
5,160 $1.16 Million
Q2 2022

Jul 21, 2022

SELL
$230.71 - $256.74 $4,383 - $4,878
-19 Reduced 0.35%
5,360 $1.3 Million
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $117,090 - $129,532
-534 Reduced 9.03%
5,379 $1.3 Million
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $31,203 - $36,558
-147 Reduced 2.43%
5,913 $1.26 Million
Q2 2021

Jul 21, 2021

SELL
$233.58 - $259.14 $186,864 - $207,312
-800 Reduced 11.66%
6,060 $1.48 Million
Q1 2021

Apr 21, 2021

SELL
$221.91 - $258.6 $221,910 - $258,600
-1,000 Reduced 12.72%
6,860 $1.71 Million
Q4 2020

Jan 25, 2021

SELL
$216.38 - $257.67 $108,190 - $128,835
-500 Reduced 5.98%
7,860 $1.81 Million
Q3 2020

Oct 22, 2020

SELL
$234.65 - $260.95 $586,625 - $652,375
-2,500 Reduced 23.02%
8,360 $2.13 Million
Q2 2020

Jul 17, 2020

SELL
$197.81 - $242.74 $98,905 - $121,370
-500 Reduced 4.4%
10,860 $2.56 Million
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $91,120 - $120,850
-500 Reduced 4.22%
11,360 $2.3 Million
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $293,653 - $377,446
-1,552 Reduced 11.57%
11,860 $2.86 Million
Q3 2019

Oct 17, 2019

BUY
$174.11 - $208.62 $788,892 - $945,257
4,531 Added 51.02%
13,412 $2.6 Million
Q2 2019

Jul 17, 2019

SELL
$166.7 - $195.41 $17,003 - $19,931
-102 Reduced 1.14%
8,881 $1.64 Million
Q1 2019

Apr 18, 2019

SELL
$180.87 - $203.88 $19,895 - $22,426
-110 Reduced 1.21%
8,983 $1.71 Million
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $7,967 - $8,982
-43 Reduced 0.47%
9,093 $1.89 Million
Q2 2018

Jul 25, 2018

SELL
$166.05 - $186.51 $33,210 - $37,302
-200 Reduced 2.14%
9,136 $1.69 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $240,251 - $280,764
-1,418 Reduced 13.19%
9,336 $1.59 Million
Q4 2017

Jan 29, 2018

SELL
$168.79 - $188.59 $164,907 - $184,252
-977 Reduced 8.33%
10,754 $1.87 Million
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $1.96 Million - $2.24 Million
11,731
11,731 $2.19 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stewart & Patten CO LLC Portfolio

Follow Stewart & Patten CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart & Patten CO LLC with notifications on news.